Vicarious Surgical (RBOT) Gains from Investment Securities (2021 - 2025)
Vicarious Surgical (RBOT) reported Gains from Investment Securities of $738483.0 for Q3 2025, up 435.13% year-over-year from $138000.0 in Q3 2024, and up 70.16% on a QoQ basis from $433983.0 in Q2 2025.
Vicarious Surgical (RBOT) has 5 years of Gains from Investment Securities data on file, last reported at $738483.0 in Q3 2025.
- Quarterly Gains from Investment Securities rose 435.13% year-over-year to $738483.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $738483.0 (up 108.81% YoY) and the FY2024 annual result came in at $709939.0, up 405.01% from the prior year.
- Gains from Investment Securities improved to $738483.0 in Q3 2025 per RBOT's latest filing, from $433983.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $19.6 million in Q2 2021 and bottomed at -$6.9 million in Q4 2023.
- The 5-year median for Gains from Investment Securities is $140577.0 (2023), against an average of $1.3 million.
- The widest annual swing landed in 2022, when Gains from Investment Securities sank 9275100.0%; it then jumped 933.33% in 2025.
- Tracing RBOT's Gains from Investment Securities over 5 years: stood at $4.0 in 2021, then slumped by 9275100.0% to -$371000.0 in 2022, then slumped by 1770.35% to -$6.9 million in 2023, then soared by 90.56% to -$655000.0 in 2024, then soared by 212.75% to $738483.0 in 2025.
- Per Business Quant, the three latest RBOT Gains from Investment Securities figures stand at $738483.0 (Q3 2025), $433983.0 (Q2 2025), and $93000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vicarious Surgical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 738,483.00 |
| Sep 30, 2025 | 738,483.00 |
| Jun 30, 2025 | 433,983.00 |
| Jun 30, 2025 | 433,983.00 |
| Mar 31, 2025 | 93,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Dec 31, 2024 | -655,000.00 |
| Dec 31, 2024 | -655,000.00 |
| Sep 30, 2024 | 138,000.00 |
| Sep 30, 2024 | 138,000.00 |
| Jun 30, 2024 | -1.59 Mn |
| Jun 30, 2024 | -1.59 Mn |
| Mar 31, 2024 | 9,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2023 | -6.94 Mn |
| Dec 31, 2023 | -6.94 Mn |
| Sep 30, 2023 | 140,577.00 |
| Sep 30, 2023 | 140,577.00 |
| Jun 30, 2023 | 21,897.00 |
| Jun 30, 2023 | 21,897.00 |
| Mar 31, 2023 | 481,764.00 |
| Mar 31, 2023 | 481,764.00 |
| Dec 31, 2022 | -371,000.00 |
| Dec 31, 2022 | -371,000.00 |
| Sep 30, 2022 | 3.04 Mn |
| Sep 30, 2022 | 3.04 Mn |
| Jun 30, 2022 | 2.97 Mn |
| Jun 30, 2022 | 2.97 Mn |
| Mar 31, 2022 | 217,000.00 |
| Mar 31, 2022 | 217,000.00 |
| Dec 31, 2021 | 4.00 |
| Dec 31, 2021 | 4.00 |
| Sep 30, 2021 | 3.79 Mn |
| Sep 30, 2021 | 3.79 Mn |
| Jun 30, 2021 | 19.57 Mn |
| Jun 30, 2021 | 19.57 Mn |
| Mar 31, 2021 | 1.73 Mn |
| Mar 31, 2021 | 1.73 Mn |